Preferred Label : aurotioprol;
MeSH note : RN given refers to Na salt; structure;
CISMeF synonym : sodium [2-hydroxy-3-mercaptopropane-1-sulphonato(2-)]aurate(1-); 3-aurothio-2-propanol-1-sulfonic acid; solvay pharma, SAS brand of aurotioprol;
MeSH synonym : sodium aurothiopropanol sulfonate; aurothiopropanol sodium sulfonate; sodium 3-aurothio-2-hydroxypropane-1-sulfonate; allochrysine;
MeSH Hyperonym : krizanol; chrysanol; chrisanol;
Related MeSH term : 3-aurothio-2-propanol-1-sulfonic acid, calcium salt; calcium 3-aurothio-2-propanol-1-sulfonate;
MeSH Related Number : chrysanol, calcium salt (2:1); 5743-29-3; 27279-43-2 (aurotioprol); US7VC71M4Y;
Registry Number MeSH : 27279-43-2;
Related CAS MeSH : 5743-29-3 (chrysanol, calcium salt (2:1));
related registry number list (CISMeF) : 5743-29-3;
Codes EINECS : 248-384-0;
Is substance : O;
UNII : G7097J63E9;
InChIKey : KBWWFTIQBJUOQR-UHFFFAOYSA-L;
Origin ID : C013394;
UMLS CUI : C0104696;
ATC code(s)
CISMeF manual mappings
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
http://www.has-sante.fr/jcms/c_1761608/fr/allochrysine
http://www.has-sante.fr/jcms/c_1761608/fr/allochrysine-traitements-de-fond-non-biologiques-de-la-polyarthrite-rhumatoide-hors-methotrexate-et-leflunomide
2014
false
false
false
France
French
evaluation of the transparency committee
evaluation of the transparency committee
injections, intramuscular
injections, intramuscular
treatment outcome
treatment outcome
aurotioprol
aurotioprol
insurance, health, reimbursement
insurance, health, reimbursement
aurotioprol
aurotioprol
arthritis, rheumatoid
arthritis, rheumatoid
rheumatic diseases
rheumatic diseases
adult
adult
child
child
antirheumatic agents
guidelines for drug use
guidelines for drug use
sulfhydryl compounds
sulfhydryl compounds
propanols
propanols
organogold compounds
organogold compounds
---